Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 29 Jul 2024

Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer

in Cancer Immunity and Immunotherapy

Wenwen Shao
Zhiheng Lin
Zhikai Xiahou
Fu Zhao
Jue Xu
Xinqi Liu
Pingping Cai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1438198

3,955 views
24 citations

Review

Published on 29 Jul 2024

Immunotherapy revolutionizing brain metastatic cancer treatment: personalized strategies for transformative outcomes

in Cancer Immunity and Immunotherapy

Ting Li
Shichen Sun
Yubing Li
Yanyu Zhang
Linlin Wei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1418580

2,596 views
2 citations

Original Research

Published on 29 Jul 2024

Multi-omics analysis of overexpressed tumor-associated proteins: gene expression, immunopeptide presentation, and antibody response in oropharyngeal squamous cell carcinoma, with a focus on cancer-testis antigens

in Cancer Immunity and Immunotherapy

Tsima Abou Kors
Matthias Meier
Lena Mühlenbruch
Annika C. Betzler
Franziska Oliveri
Martin Bens
Jaya Thomas
Johann M. Kraus
Johannes Doescher
Adrian von Witzleben

Frontiers in Immunology

doi 10.3389/fimmu.2024.1408173

2,854 views
1 citation

Original Research

Published on 29 Jul 2024

The distribution and maturation of tertiary lymphoid structures can predict clinical outcomes of patients with gastric adenocarcinoma

in Cancer Immunity and Immunotherapy

Hui Sun
Yuxi Liu
Wanjing Cheng
Rong Xiong
Wenchao Gu
Xiaoyan Zhang
Xin Wang
Xu Wang
Cong Tan
Weiwei Weng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1396808

2,634 views
3 citations

Review

Published on 29 Jul 2024

Organoids: new frontiers in tumor immune microenvironment research

in Cancer Immunity and Immunotherapy

Yujia Yang
Jinlei Cui
Yajie Kong
Yu Hou
Cuiqing Ma

Frontiers in Immunology

doi 10.3389/fimmu.2024.1422031

3,790 views
1 citation

Review

Published on 29 Jul 2024

Current status and future directions of nanovaccine for cancer: a bibliometric analysis during 2004-2023

in Cancer Immunity and Immunotherapy

Yuhui Hou
Yue Li
Youao Zhang
Juan Zhang
Dinglan Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1423212

3,312 views
2 citations

Original Research

Published on 29 Jul 2024

Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Takahiro Tsujikawa
Kazuchika Ohno
Kei-ichi Morita
Sumiyo Saburi
Junichi Mitsuda
Kanako Yoshimura
Alisa Kimura
Hiroki Morimoto
Hiroshi Ogi
Saya Shibata

Frontiers in Immunology

doi 10.3389/fimmu.2024.1390873

3,409 views
1 citation

Original Research

Published on 26 Jul 2024

TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study

in Cancer Immunity and Immunotherapy

Song Chen
Tang Shuangyan
Feng Shi
Hongjie Cai
Zhiqiang Wu
Liguang Wang
Ping Ma
Yuanmin Zhou
Qicong Mai
Fan Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1430571

2,203 views
1 citation

Original Research

Published on 26 Jul 2024

CD47;Rag2;IL-2rγ triple knock-out mice pre-conditioning with busulfan could be a novel platform for generating hematopoietic stem cells engrafted humanized mice

in Cancer Immunity and Immunotherapy

Kang-Hyun Kim
Sang-wook Lee
In-Jeoung Baek
Hye-Young Song
Seon-Ju Jo
Je-Won Ryu
Seung-Hee Ryu
Jin-Hee Seo
Jong-Choon Kim
Seung-Ho Heo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1365946

1,706 views

Case Report

Published on 26 Jul 2024

Chronic hepatitis E virus-induced spinal cord atrophy in a patient with chronic lymphatic leukemia: a case report and interdisciplinary management proposal

in Cancer Immunity and Immunotherapy

Marvin Ritter
Olaposi Yomade
Ben-Ole Holtz
Stefanie Deinhardt-Emmer
Aaron Lawson McLean
Stefanie Hartinger
Julia Bechwar
Matthias Schwab
André Huss
Christian Mawrin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1445944

1,435 views
2 citations

Review

Published on 25 Jul 2024

Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy

in Cancer Immunity and Immunotherapy

Andrea Nicolini
Paola Ferrari

Frontiers in Immunology

doi 10.3389/fimmu.2024.1353787

7,937 views
5 citations

Original Research

Published on 25 Jul 2024

Intelligent electromagnetic navigation system for robot-assisted intraoral osteotomy in mandibular tumor resection: a model experiment

in Cancer Immunity and Immunotherapy

Zhijie Zhao
Yichi Zhang
Li Lin
Wenyi Huang
Can Xiao
Jiannan Liu
Gang Chai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1436276

1,753 views
1 citation

Original Research

Published on 25 Jul 2024

A m6A regulators-related classifier for prognosis and tumor microenvironment characterization in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Shaohua Xu
Yi Zhang
Ying Yang
Kexin Dong
Hanfei Zhang
Chunhua Luo
Song-Mei Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374465

2,048 views
1 citation

Original Research

Published on 24 Jul 2024

A common secretomic signature across epithelial cancers metastatic to the pleura supports IL-6 axis therapeutic targeting

in Cancer Immunity and Immunotherapy

Vera S. Donnenberg
James D. Luketich
Bosko Popov
David L. Bartlett
Albert D. Donnenberg

Frontiers in Immunology

doi 10.3389/fimmu.2024.1404373

1,503 views

Original Research

Published on 24 Jul 2024

Construction of a nomogram with IrAE and clinic character to predict the survival of advanced G/GEJ adenocarcinoma patients undergoing anti-PD-1 treatment

in Cancer Immunity and Immunotherapy

Han Wang
Jinhua Chen
Wei Gao
Yilan Wu
Xinli Wang
Fangyu Lin
Hao Chen
Yao Wang
Tao Jiang
Zhangchi Pan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1432281

2,331 views
2 citations

Case Report

Published on 24 Jul 2024

Treatment of intracranial inflammatory myofibroblastic tumor with PD-L1 inhibitor and novel oncolytic adenovirus Ad-TD-nsIL12: a case report and literature review

in Cancer Immunity and Immunotherapy

Xiao Qian
Weihai Ning
Louisa Chard Dunmall
Yanming Qu
Yaohe Wang
Hongwei Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1427554

1,493 views
2 citations

Navigation group

Articles

Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer

Immunotherapy revolutionizing brain metastatic cancer treatment: personalized strategies for transformative outcomes

Multi-omics analysis of overexpressed tumor-associated proteins: gene expression, immunopeptide presentation, and antibody response in oropharyngeal squamous cell carcinoma, with a focus on cancer-testis antigens

The distribution and maturation of tertiary lymphoid structures can predict clinical outcomes of patients with gastric adenocarcinoma

Organoids: new frontiers in tumor immune microenvironment research

Current status and future directions of nanovaccine for cancer: a bibliometric analysis during 2004-2023

Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinoma

TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study

CD47;Rag2;IL-2rγ triple knock-out mice pre-conditioning with busulfan could be a novel platform for generating hematopoietic stem cells engrafted humanized mice

Chronic hepatitis E virus-induced spinal cord atrophy in a patient with chronic lymphatic leukemia: a case report and interdisciplinary management proposal

Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy

Intelligent electromagnetic navigation system for robot-assisted intraoral osteotomy in mandibular tumor resection: a model experiment

A m6A regulators-related classifier for prognosis and tumor microenvironment characterization in hepatocellular carcinoma

A common secretomic signature across epithelial cancers metastatic to the pleura supports IL-6 axis therapeutic targeting

Construction of a nomogram with IrAE and clinic character to predict the survival of advanced G/GEJ adenocarcinoma patients undergoing anti-PD-1 treatment

Treatment of intracranial inflammatory myofibroblastic tumor with PD-L1 inhibitor and novel oncolytic adenovirus Ad-TD-nsIL12: a case report and literature review